TABLE 1.
Antimicrobial compounds and conditions inducing VSH-1
Treatment | Antimicrobial concn
|
hvp38 transcription (fold increase)a | VSH-1 productionb
|
||
---|---|---|---|---|---|
μg/ml | μM | DNA | EM | ||
Control (untreated) | 1 | − | − | ||
Mitomycin C | 10 | 30 | 260 | + | + |
Metronidazole | 0.5 | 2.5 | 720 | + | + |
0.05 | 0.25 | 50 | + | − | |
0.005 | 0.025 | 7 | − | − | |
Carbadox | 0.5 | 1.9 | 290 | + | + |
0.05 | 0.19 | 30 | + | + | |
0.005 | 0.019 | 14 | − | − | |
H2O2 | 300 | 100 | + | + |
Increase in hvp38 transcription over untreated (control) cultures. Levels of hvp38 mRNA in control cultures were arbitrarily standardized to a value of 1. An increase of 5-fold or greater in each of triplicate cultures undergoing a particular treatment was considered significant. The values are mean values for at least two experiments. The following antimicrobials at the indicated concentrations (μg/ml) were not found to stimulate hvp38 transcription: chlortetracycline (5, 10, 50), lincomycin (10, 50, 100), tylosin (500, 1,000), tiamulin (0.02, 0.1), virginiamycin (3), ampicillin (3, 15), ceftriaxone (30), vancomycin (500, 1,000), and florfenicol (2, 10, 20).